CD4 and cancer: In a mouse model of cancer cachexia, the adoptive transfer of CD4+CD44Low naïve T-cells reduces muscle atrophy, muscle protein and DNA loss, even when inoculated after the onset of cachexia, associated with a protection from CD4+ T-cell lymphopenia (Wang et al., 2008).